The FDA has long been criticized for the slowness and caution of its practices in reviewing and approving new drugs and medical devices. It has since become a prime target of manufacturers eager to get products on the market, as it sometimes takes years to review and approve new products. Under the new program, drug makers pay a fee that the FDA uses to hire independent reviewers which analyze the safety and effectiveness of medications, in turn speeding up the entire process. It also aims to speed up approval of medical devices, one of the most controversial aspects of the bill. Although receiving praise from many supporters, the bill has not gone uncriticized.
Voters can clearly see that senators think industry profits are more important than public health.
While other therapeutic alternatives have become available, radical prostatectomy is the most commonly administered treatment option for prostate cancer. While the popular nerve-sparing procedure is intended to promote erectile function by sparing one or both of the neurovascular bundles which incorporate the cavernous nerves, this machine will help avoid those integral sections of the anatomy. After all components are attached, the surgeon utilizes a probe to locate the nerves and check for responses. Based on responses gathered, strategic dissections are made in order to remove the cancer. Although no extensive studies have been implemented, urologists are advocating its use but using it with precaution.